ENPP1 and neoplasm: ENPP1 inhibits pro-inflammatory cytokine production, stimulates anti-inflammatory cytokine synthesis, and leverages two GPCR receptors (A2a A2b) to hydrolyze ATP, contributing to increased adenosine signaling in the hypoxic tumor microenvironment of metastatic PCa [40–42].